Condition: Duchenne Muscular Dystrophy · Sponsor: Ning Wang, MD., PhD.
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.
This description comes directly from the study's public registry record.
Ning Wang, MD, PhD · 13805015340 · ningwang@fjmu.edu.cn
Ming Jin, MD · Safariday@live.com
Always discuss trial participation with your own doctor first.
| First Affiliated Hospital of Fujian Medical University | Fuzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04012671